Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-25

FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc., granting updated marketing authorization for the generic Clozapin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)